JP2002502371A - アクリジン誘導体多剤耐性阻害薬の合成 - Google Patents
アクリジン誘導体多剤耐性阻害薬の合成Info
- Publication number
- JP2002502371A JP2002502371A JP54995998A JP54995998A JP2002502371A JP 2002502371 A JP2002502371 A JP 2002502371A JP 54995998 A JP54995998 A JP 54995998A JP 54995998 A JP54995998 A JP 54995998A JP 2002502371 A JP2002502371 A JP 2002502371A
- Authority
- JP
- Japan
- Prior art keywords
- formula
- compound
- mixture
- synthesis
- hours
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 230000015572 biosynthetic process Effects 0.000 title claims abstract description 13
- 238000003786 synthesis reaction Methods 0.000 title claims abstract description 13
- 239000003112 inhibitor Substances 0.000 title description 4
- 230000036457 multidrug resistance Effects 0.000 title description 2
- 125000000641 acridinyl group Chemical class C1(=CC=CC2=NC3=CC=CC=C3C=C12)* 0.000 title 1
- 230000008878 coupling Effects 0.000 claims abstract description 13
- 238000010168 coupling process Methods 0.000 claims abstract description 13
- 238000005859 coupling reaction Methods 0.000 claims abstract description 13
- INBURRUOTJXJKO-UHFFFAOYSA-N 1-(2-phenylethyl)isoquinolin-3-amine Chemical compound N=1C(N)=CC2=CC=CC=C2C=1CCC1=CC=CC=C1 INBURRUOTJXJKO-UHFFFAOYSA-N 0.000 claims abstract description 6
- ZMXDDKWLCZADIW-UHFFFAOYSA-N N,N-Dimethylformamide Chemical group CN(C)C=O ZMXDDKWLCZADIW-UHFFFAOYSA-N 0.000 claims description 24
- 150000001875 compounds Chemical class 0.000 claims description 24
- 238000000034 method Methods 0.000 claims description 20
- -1 1H-benzotriazol-1-yl Chemical group 0.000 claims description 13
- ZMANZCXQSJIPKH-UHFFFAOYSA-N Triethylamine Chemical group CCN(CC)CC ZMANZCXQSJIPKH-UHFFFAOYSA-N 0.000 claims description 12
- 239000012458 free base Substances 0.000 claims description 11
- 239000003153 chemical reaction reagent Substances 0.000 claims description 9
- 239000002585 base Substances 0.000 claims description 7
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 claims description 6
- AVQQQNCBBIEMEU-UHFFFAOYSA-N 1,1,3,3-tetramethylurea Chemical group CN(C)C(=O)N(C)C AVQQQNCBBIEMEU-UHFFFAOYSA-N 0.000 claims description 5
- 238000006243 chemical reaction Methods 0.000 claims description 5
- 239000012026 peptide coupling reagents Substances 0.000 claims description 4
- 229960000583 acetic acid Drugs 0.000 claims description 3
- 239000007822 coupling agent Substances 0.000 claims description 3
- 239000012362 glacial acetic acid Substances 0.000 claims description 3
- 239000003880 polar aprotic solvent Substances 0.000 claims description 3
- 238000005897 peptide coupling reaction Methods 0.000 claims description 2
- 150000001412 amines Chemical class 0.000 claims 3
- 150000003840 hydrochlorides Chemical class 0.000 claims 1
- 230000002194 synthesizing effect Effects 0.000 claims 1
- 239000002253 acid Substances 0.000 abstract description 6
- 230000009466 transformation Effects 0.000 abstract 1
- 239000000203 mixture Substances 0.000 description 26
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 20
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 18
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 18
- WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 description 15
- VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 description 12
- 239000002002 slurry Substances 0.000 description 11
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 10
- WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical compound C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 description 9
- 238000003756 stirring Methods 0.000 description 9
- 239000000725 suspension Substances 0.000 description 9
- BWHMMNNQKKPAPP-UHFFFAOYSA-L potassium carbonate Chemical compound [K+].[K+].[O-]C([O-])=O BWHMMNNQKKPAPP-UHFFFAOYSA-L 0.000 description 8
- 238000010992 reflux Methods 0.000 description 8
- 239000000543 intermediate Substances 0.000 description 7
- 229910052757 nitrogen Inorganic materials 0.000 description 7
- 239000000047 product Substances 0.000 description 7
- IJGRMHOSHXDMSA-UHFFFAOYSA-N nitrogen Substances N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 6
- NLKNQRATVPKPDG-UHFFFAOYSA-M potassium iodide Chemical compound [K+].[I-] NLKNQRATVPKPDG-UHFFFAOYSA-M 0.000 description 6
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 5
- 239000012317 TBTU Substances 0.000 description 5
- CLZISMQKJZCZDN-UHFFFAOYSA-N [benzotriazol-1-yloxy(dimethylamino)methylidene]-dimethylazanium Chemical compound C1=CC=C2N(OC(N(C)C)=[N+](C)C)N=NC2=C1 CLZISMQKJZCZDN-UHFFFAOYSA-N 0.000 description 5
- 239000000706 filtrate Substances 0.000 description 5
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 description 5
- 239000012265 solid product Substances 0.000 description 5
- HOXCITDDHKZNLF-UHFFFAOYSA-N 3-nitro-1-(2-phenylethyl)isoquinoline Chemical compound N=1C([N+](=O)[O-])=CC2=CC=CC=C2C=1CCC1=CC=CC=C1 HOXCITDDHKZNLF-UHFFFAOYSA-N 0.000 description 4
- 239000001257 hydrogen Substances 0.000 description 4
- 229910052739 hydrogen Inorganic materials 0.000 description 4
- XHXFXVLFKHQFAL-UHFFFAOYSA-N phosphoryl trichloride Chemical compound ClP(Cl)(Cl)=O XHXFXVLFKHQFAL-UHFFFAOYSA-N 0.000 description 4
- 229910000027 potassium carbonate Inorganic materials 0.000 description 4
- YLQBMQCUIZJEEH-UHFFFAOYSA-N tetrahydrofuran Natural products C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 description 4
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 description 3
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 description 3
- 239000006227 byproduct Substances 0.000 description 3
- PFKFTWBEEFSNDU-UHFFFAOYSA-N carbonyldiimidazole Chemical compound C1=CN=CN1C(=O)N1C=CN=C1 PFKFTWBEEFSNDU-UHFFFAOYSA-N 0.000 description 3
- 238000002425 crystallisation Methods 0.000 description 3
- 230000008025 crystallization Effects 0.000 description 3
- UAOMVDZJSHZZME-UHFFFAOYSA-N diisopropylamine Chemical compound CC(C)NC(C)C UAOMVDZJSHZZME-UHFFFAOYSA-N 0.000 description 3
- 238000001914 filtration Methods 0.000 description 3
- 125000000956 methoxy group Chemical group [H]C([H])([H])O* 0.000 description 3
- 239000012299 nitrogen atmosphere Substances 0.000 description 3
- 239000011541 reaction mixture Substances 0.000 description 3
- 239000002904 solvent Substances 0.000 description 3
- BGRWYRAHAFMIBJ-UHFFFAOYSA-N 1,3-di(propan-2-yl)urea Chemical compound CC(C)NC(=O)NC(C)C BGRWYRAHAFMIBJ-UHFFFAOYSA-N 0.000 description 2
- NTURQZFFJDCTMZ-UHFFFAOYSA-N 1-(2-bromoethyl)-4-nitrobenzene Chemical compound [O-][N+](=O)C1=CC=C(CCBr)C=C1 NTURQZFFJDCTMZ-UHFFFAOYSA-N 0.000 description 2
- XRXMNWGCKISMOH-UHFFFAOYSA-N 2-bromobenzoic acid Chemical compound OC(=O)C1=CC=CC=C1Br XRXMNWGCKISMOH-UHFFFAOYSA-N 0.000 description 2
- SXOPCLUOUFQBJV-UHFFFAOYSA-N 3-methoxyanthranilic acid Chemical compound COC1=CC=CC(C(O)=O)=C1N SXOPCLUOUFQBJV-UHFFFAOYSA-N 0.000 description 2
- QCQCHGYLTSGIGX-GHXANHINSA-N 4-[[(3ar,5ar,5br,7ar,9s,11ar,11br,13as)-5a,5b,8,8,11a-pentamethyl-3a-[(5-methylpyridine-3-carbonyl)amino]-2-oxo-1-propan-2-yl-4,5,6,7,7a,9,10,11,11b,12,13,13a-dodecahydro-3h-cyclopenta[a]chrysen-9-yl]oxy]-2,2-dimethyl-4-oxobutanoic acid Chemical compound N([C@@]12CC[C@@]3(C)[C@]4(C)CC[C@H]5C(C)(C)[C@@H](OC(=O)CC(C)(C)C(O)=O)CC[C@]5(C)[C@H]4CC[C@@H]3C1=C(C(C2)=O)C(C)C)C(=O)C1=CN=CC(C)=C1 QCQCHGYLTSGIGX-GHXANHINSA-N 0.000 description 2
- SHOWAGCIRTUYNA-UHFFFAOYSA-N 6,7-dimethoxy-1,2,3,4-tetrahydroisoquinoline;hydron;chloride Chemical compound [Cl-].C1C[NH2+]CC2=C1C=C(OC)C(OC)=C2 SHOWAGCIRTUYNA-UHFFFAOYSA-N 0.000 description 2
- RYGMFSIKBFXOCR-UHFFFAOYSA-N Copper Chemical compound [Cu] RYGMFSIKBFXOCR-UHFFFAOYSA-N 0.000 description 2
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 2
- SECXISVLQFMRJM-UHFFFAOYSA-N N-Methylpyrrolidone Chemical compound CN1CCCC1=O SECXISVLQFMRJM-UHFFFAOYSA-N 0.000 description 2
- JUJWROOIHBZHMG-UHFFFAOYSA-N Pyridine Chemical compound C1=CC=NC=C1 JUJWROOIHBZHMG-UHFFFAOYSA-N 0.000 description 2
- 238000010521 absorption reaction Methods 0.000 description 2
- 229940125665 acridine carboxamide Drugs 0.000 description 2
- 239000002246 antineoplastic agent Substances 0.000 description 2
- 239000003054 catalyst Substances 0.000 description 2
- 239000013078 crystal Substances 0.000 description 2
- 229940127089 cytotoxic agent Drugs 0.000 description 2
- 239000012065 filter cake Substances 0.000 description 2
- XBGNERSKEKDZDS-UHFFFAOYSA-N n-[2-(dimethylamino)ethyl]acridine-4-carboxamide Chemical compound C1=CC=C2N=C3C(C(=O)NCCN(C)C)=CC=CC3=CC2=C1 XBGNERSKEKDZDS-UHFFFAOYSA-N 0.000 description 2
- QJGQUHMNIGDVPM-UHFFFAOYSA-N nitrogen group Chemical group [N] QJGQUHMNIGDVPM-UHFFFAOYSA-N 0.000 description 2
- 238000010647 peptide synthesis reaction Methods 0.000 description 2
- 208000016691 refractory malignant neoplasm Diseases 0.000 description 2
- 150000003839 salts Chemical class 0.000 description 2
- 239000007858 starting material Substances 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- ASOKPJOREAFHNY-UHFFFAOYSA-N 1-Hydroxybenzotriazole Chemical compound C1=CC=C2N(O)N=NC2=C1 ASOKPJOREAFHNY-UHFFFAOYSA-N 0.000 description 1
- SMZOUWXMTYCWNB-UHFFFAOYSA-N 2-(2-methoxy-5-methylphenyl)ethanamine Chemical compound COC1=CC=C(C)C=C1CCN SMZOUWXMTYCWNB-UHFFFAOYSA-N 0.000 description 1
- NIXOWILDQLNWCW-UHFFFAOYSA-N 2-Propenoic acid Natural products OC(=O)C=C NIXOWILDQLNWCW-UHFFFAOYSA-N 0.000 description 1
- QOSSAOTZNIDXMA-UHFFFAOYSA-N Dicylcohexylcarbodiimide Chemical compound C1CCCCC1N=C=NC1CCCCC1 QOSSAOTZNIDXMA-UHFFFAOYSA-N 0.000 description 1
- 238000005481 NMR spectroscopy Methods 0.000 description 1
- ZLMJMSJWJFRBEC-LZFNBGRKSA-N Potassium-45 Chemical compound [45K] ZLMJMSJWJFRBEC-LZFNBGRKSA-N 0.000 description 1
- 150000001251 acridines Chemical class 0.000 description 1
- 230000003213 activating effect Effects 0.000 description 1
- 239000012190 activator Substances 0.000 description 1
- 239000008186 active pharmaceutical agent Substances 0.000 description 1
- 150000003973 alkyl amines Chemical class 0.000 description 1
- 150000001408 amides Chemical class 0.000 description 1
- 229940027998 antiseptic and disinfectant acridine derivative Drugs 0.000 description 1
- 150000004982 aromatic amines Chemical class 0.000 description 1
- 239000004202 carbamide Substances 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 229940043279 diisopropylamine Drugs 0.000 description 1
- MKRTXPORKIRPDG-UHFFFAOYSA-N diphenylphosphoryl azide Chemical compound C=1C=CC=CC=1P(=O)(N=[N+]=[N-])C1=CC=CC=C1 MKRTXPORKIRPDG-UHFFFAOYSA-N 0.000 description 1
- 238000004090 dissolution Methods 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 150000002170 ethers Chemical class 0.000 description 1
- 150000008282 halocarbons Chemical class 0.000 description 1
- 238000004128 high performance liquid chromatography Methods 0.000 description 1
- 125000004435 hydrogen atom Chemical group [H]* 0.000 description 1
- 239000012442 inert solvent Substances 0.000 description 1
- 150000002576 ketones Chemical class 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 238000002844 melting Methods 0.000 description 1
- 230000008018 melting Effects 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- XTUSEBKMEQERQV-UHFFFAOYSA-N propan-2-ol;hydrate Chemical compound O.CC(C)O XTUSEBKMEQERQV-UHFFFAOYSA-N 0.000 description 1
- 238000000425 proton nuclear magnetic resonance spectrum Methods 0.000 description 1
- 238000010926 purge Methods 0.000 description 1
- UMJSCPRVCHMLSP-UHFFFAOYSA-N pyridine Natural products COC1=CC=CN=C1 UMJSCPRVCHMLSP-UHFFFAOYSA-N 0.000 description 1
- 230000001235 sensitizing effect Effects 0.000 description 1
- 239000012453 solvate Substances 0.000 description 1
- 150000003672 ureas Chemical class 0.000 description 1
- 238000005406 washing Methods 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D219/00—Heterocyclic compounds containing acridine or hydrogenated acridine ring systems
- C07D219/04—Heterocyclic compounds containing acridine or hydrogenated acridine ring systems with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the ring system
- C07D219/06—Oxygen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D217/00—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems
- C07D217/22—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the nitrogen-containing ring
- C07D217/24—Oxygen atoms
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Steroid Compounds (AREA)
- Pyridine Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Peptides Or Proteins (AREA)
Abstract
Description
Claims (1)
- 【特許請求の範囲】 1. 式(IV) の化合物の合成法であって、 (i)式(II) の化合物と、式(III) の化合物をカップリング試薬の存在下にて反応させて、式(IV)の遊離塩基を 生成させ、 (ii) 場合によっては、式(IV)の化合物を式(I) のHCl塩に転換する 工程を含んでなる、方法。 2. カップリング試薬がテトラメチルウロニウムを基剤とするペプチドカッ プリング試薬である、請求項1に記載の方法。 3. カップリング試薬が2−(1H−ベンゾトリアゾール−1−イル)−1 ,1,3,3−テトラメチルウロニウムテトラフルオロボレートである、請求項 2に記載の方法。 4. アミン塩基をも含む、請求項2に記載の方法。 5. アミン塩基がトリエチルアミンである、請求項4に記載の方法。 6. 反応が約20〜25℃で起こる、請求項1に記載の方法。 7. 反応が少なくとも1時間起こる、請求項1に記載の方法。 8. 上記カップリングエ程を約20〜25℃で行う、請求項1に記載の方法 。 9. 化合物(II)および(III)を極性の非プロトン性溶媒に溶解した 後、カップリング剤を添加する、請求項1に記載の方法。 10. 極性の非プロトン性溶媒がジメチルホルムアミドである、請求項9に 記載の方法。 11. 式(I) の化合物の合成法であって、 i) 式(II) のアクリドン酸と、式(III)のアミノフェネチルイソキノリンとを、アミン塩基の存在下にてテトラメチルウ ロニウムを基剤とするペプチドカップリング剤と反応させて、式(IV) の遊離塩基を生成させ、 ii) 式(IV)の遊離塩基を式(I)の化合物に転換する 工程を含んでなる、方法。 12. 式(IV)の遊離塩基を氷酢酸の存在下にて転換する、請求項11 に記載の方法。 13. 上記カップリング工程が約3時間起こる、請求項11に記載の方法。
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GBGB9710612.4A GB9710612D0 (en) | 1997-05-23 | 1997-05-23 | Synthesis of acridine derivatives |
GB9710612.4 | 1997-05-23 | ||
PCT/EP1998/002991 WO1998052923A1 (en) | 1997-05-23 | 1998-05-22 | Synthesis of acridine derivative multidrug-resistant inhibitors |
Publications (2)
Publication Number | Publication Date |
---|---|
JP2002502371A true JP2002502371A (ja) | 2002-01-22 |
JP4390861B2 JP4390861B2 (ja) | 2009-12-24 |
Family
ID=10812906
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP54995998A Expired - Fee Related JP4390861B2 (ja) | 1997-05-23 | 1998-05-22 | アクリジン誘導体多剤耐性阻害薬の合成 |
Country Status (19)
Country | Link |
---|---|
US (1) | US6248891B1 (ja) |
EP (1) | EP0983246B1 (ja) |
JP (1) | JP4390861B2 (ja) |
KR (1) | KR100536155B1 (ja) |
CN (1) | CN1178918C (ja) |
AT (1) | ATE228506T1 (ja) |
AU (1) | AU744402B2 (ja) |
BR (1) | BR9809143A (ja) |
CA (1) | CA2289492C (ja) |
DE (1) | DE69809733T2 (ja) |
DK (1) | DK0983246T3 (ja) |
ES (1) | ES2187984T3 (ja) |
GB (1) | GB9710612D0 (ja) |
HK (1) | HK1023995A1 (ja) |
HU (1) | HUP0002083A3 (ja) |
IL (1) | IL132593A (ja) |
PL (1) | PL190109B1 (ja) |
PT (1) | PT983246E (ja) |
WO (1) | WO1998052923A1 (ja) |
Families Citing this family (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB9708805D0 (en) | 1997-05-01 | 1997-06-25 | Smithkline Beecham Plc | Compounds |
GB9810876D0 (en) | 1998-05-20 | 1998-07-22 | Smithkline Beecham Plc | Compounds |
EA200100428A1 (ru) | 1998-10-08 | 2001-10-22 | Смитклайн Бичам Плс | Производные тетрагидробензазепина, полезные в качестве модуляторов допаминовых d3 рецепторов (антипсихотические агенты) |
ES2270834T3 (es) * | 1999-05-17 | 2007-04-16 | Cancer Research Ventures Limited | Composiciones para mejorar la biodisponibilidad de farmacos administrados oralmente. |
SI21507A (sl) | 2003-05-16 | 2004-12-31 | LEK farmacevtska dru�ba d.d. | Postopek za pripravo spojin z ace inhibitornim delovanjem |
US7829578B1 (en) | 2005-12-12 | 2010-11-09 | Oregon Health & Science University | Aromatic ketones and uses thereof |
WO2008064011A1 (en) | 2006-11-13 | 2008-05-29 | The Government Of The U.S. Of America As Represented By The Department Of Veterans Affairs | Acridone compounds |
US8598354B2 (en) | 2008-12-05 | 2013-12-03 | University Of South Florida | Compounds having antiparasitic or anti-infectious activity |
IL277335B2 (en) * | 2018-03-21 | 2024-03-01 | Izumi Tech Llc | Analogues of alcridar with deuterium |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0494623A1 (en) * | 1991-01-11 | 1992-07-15 | Laboratoires Glaxo Sa | Acridine derivatives |
CZ104197A3 (en) * | 1994-10-05 | 1997-09-17 | Glaxo Wellcome Inc | Pharmaceutical preparation |
-
1997
- 1997-05-23 GB GBGB9710612.4A patent/GB9710612D0/en active Pending
-
1998
- 1998-05-22 CA CA002289492A patent/CA2289492C/en not_active Expired - Fee Related
- 1998-05-22 AU AU84344/98A patent/AU744402B2/en not_active Ceased
- 1998-05-22 JP JP54995998A patent/JP4390861B2/ja not_active Expired - Fee Related
- 1998-05-22 CN CNB988051265A patent/CN1178918C/zh not_active Expired - Fee Related
- 1998-05-22 BR BR9809143-3A patent/BR9809143A/pt not_active Application Discontinuation
- 1998-05-22 PT PT98934892T patent/PT983246E/pt unknown
- 1998-05-22 WO PCT/EP1998/002991 patent/WO1998052923A1/en active IP Right Grant
- 1998-05-22 DE DE69809733T patent/DE69809733T2/de not_active Expired - Lifetime
- 1998-05-22 PL PL98336937A patent/PL190109B1/pl not_active IP Right Cessation
- 1998-05-22 HU HU0002083A patent/HUP0002083A3/hu unknown
- 1998-05-22 DK DK98934892T patent/DK0983246T3/da active
- 1998-05-22 AT AT98934892T patent/ATE228506T1/de not_active IP Right Cessation
- 1998-05-22 ES ES98934892T patent/ES2187984T3/es not_active Expired - Lifetime
- 1998-05-22 EP EP98934892A patent/EP0983246B1/en not_active Expired - Lifetime
- 1998-05-22 US US09/403,158 patent/US6248891B1/en not_active Expired - Fee Related
- 1998-05-22 KR KR10-1999-7010781A patent/KR100536155B1/ko not_active IP Right Cessation
- 1998-05-22 IL IL13259398A patent/IL132593A/en not_active IP Right Cessation
-
2000
- 2000-05-25 HK HK00103130A patent/HK1023995A1/xx not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
HUP0002083A3 (en) | 2002-03-28 |
EP0983246B1 (en) | 2002-11-27 |
KR20010012817A (ko) | 2001-02-26 |
BR9809143A (pt) | 2000-08-01 |
DK0983246T3 (da) | 2003-03-24 |
HUP0002083A2 (hu) | 2001-04-28 |
GB9710612D0 (en) | 1997-07-16 |
CA2289492A1 (en) | 1998-11-26 |
IL132593A (en) | 2004-07-25 |
US6248891B1 (en) | 2001-06-19 |
JP4390861B2 (ja) | 2009-12-24 |
ATE228506T1 (de) | 2002-12-15 |
CN1255918A (zh) | 2000-06-07 |
PL336937A1 (en) | 2000-07-17 |
CA2289492C (en) | 2009-03-24 |
IL132593A0 (en) | 2001-03-19 |
WO1998052923A1 (en) | 1998-11-26 |
ES2187984T3 (es) | 2003-06-16 |
EP0983246A1 (en) | 2000-03-08 |
PL190109B1 (pl) | 2005-10-31 |
AU8434498A (en) | 1998-12-11 |
AU744402B2 (en) | 2002-02-21 |
HK1023995A1 (en) | 2000-09-29 |
DE69809733D1 (de) | 2003-01-09 |
CN1178918C (zh) | 2004-12-08 |
PT983246E (pt) | 2003-04-30 |
KR100536155B1 (ko) | 2005-12-14 |
DE69809733T2 (de) | 2003-09-18 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP5264830B2 (ja) | アミノクロトニル化合物の調製方法 | |
AU2020267299B2 (en) | Methods of making protein deacetylase inhibitors | |
JP2009503120A (ja) | イマチニブの調製方法 | |
WO2011113369A1 (zh) | 氘代甲胺及其盐的制备方法 | |
JP2002511386A (ja) | アミド形成反応のための触媒およびその方法 | |
CN112209938B (zh) | 2-吲哚啉螺环酮类化合物的制备方法及其中间体 | |
JP2002502371A (ja) | アクリジン誘導体多剤耐性阻害薬の合成 | |
JP4208463B2 (ja) | キノロンカルボン酸誘導体の製造に関する中間体 | |
AU2022207035A1 (en) | Synthesis method for aminopyrimidine fak inhibitor compound | |
TW202210486A (zh) | 一種製備glp—1受體激動劑的方法 | |
JP2002513021A (ja) | 1,3−二置換−4−オキソ環式尿素の製造方法 | |
IE45423B1 (en) | Process for hypotensive 2-(4-substituted piperazin-1-yl)-4-aminoquinazolines | |
JP2002513022A (ja) | 1,3−二置換−4−オキソ環式尿素の製造方法 | |
JP2648165B2 (ja) | ベルゾ(カルコゲノ)〔4,3,2−cd〕インダゾールの調製方法 | |
JP3711625B2 (ja) | 1H−ピラゾロ[3,2−c]−1,2,4−トリアゾール系化合物の製造方法 | |
JPH1112254A (ja) | 3−(3−ピリジルメチルアミノ)−3,4−ジヒドロ−2(1h)−キナゾリノン誘導体及びその中間体の製造方法 | |
CA2570179A1 (en) | Method for producing acetamidopyrrolidine derivative and intermediate compound thereof | |
KR101152607B1 (ko) | 6-[4-(2-피페리딘-1-일-에톡시)-페닐]-3-피리딘-4-일-피라졸로[1,5-a]피리미딘의 제조방법 | |
CN116063318A (zh) | 一种瑞卢戈利及其中间体的制备方法 | |
JPH07285921A (ja) | 2−アミノ−N−(β−ヒドロキシフェネチル)アセトアミド誘導体の製造方法 | |
JPH0211562A (ja) | 4―メチル―3―チオセミカルバジドの製造法 | |
JP2001278864A (ja) | 4−メトキシキノリン類の製造方法 | |
JP2002525278A (ja) | 特定のフェニル尿素化合物の製造方法 | |
JP2001278865A (ja) | 4−アミノキノリン類の製造方法 | |
JPH06157497A (ja) | メルカプトイミダゾール誘導体の製造方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20050517 |
|
A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20090203 |
|
A601 | Written request for extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A601 Effective date: 20090428 |
|
A602 | Written permission of extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A602 Effective date: 20090615 |
|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20090731 |
|
TRDD | Decision of grant or rejection written | ||
A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 Effective date: 20090908 |
|
A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 |
|
A61 | First payment of annual fees (during grant procedure) |
Free format text: JAPANESE INTERMEDIATE CODE: A61 Effective date: 20091007 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20121016 Year of fee payment: 3 |
|
R150 | Certificate of patent or registration of utility model |
Free format text: JAPANESE INTERMEDIATE CODE: R150 |
|
LAPS | Cancellation because of no payment of annual fees |